Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Dysbiosis: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Associated Genes | AGING, ALZHEIMER, ALZHEIMER'S DISEASE, ANXIETY, AUTOPHAGY, C3AR1, CANCER, CRHR1 |
| KG Connections | 341 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
graph TD
Dysbiosis["Dysbiosis"]
Parkinson_s_Disease{"Parkinson's Disease"}
Dysbiosis -->|"risk_factor_for"| Parkinson_s_Disease
Neuroinflammation["Neuroinflammation"]
Dysbiosis -->|"causes"| Neuroinflammation
Blood_Brain_Barrier_Permeabili["Blood-Brain Barrier Permeability"]
Dysbiosis -->|"causes"| Blood_Brain_Barrier_Permeabili
Inflammation{"Inflammation"}
Inflammation -->|"associated_with"| Dysbiosis
Als{"Als"}
Als -->|"therapeutic_target"| Dysbiosis
INFLAMMATION(["INFLAMMATION"])
INFLAMMATION -->|"associated_with"| Dysbiosis
style Dysbiosis fill:#1a3a4a,stroke:#ef5350,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| depression | associated_with | disease | 0.95 |
| Oxidative Stress | contributes_to | process | 0.90 |
| Oxidative Stress | promotes | process | 0.90 |
| Neuroinflammation | promotes | process | 0.90 |
| Neuroinflammation | causes | process | 0.90 |
| Parkinson's Disease | associated_with | disease | 0.90 |
| NEUROINFLAMMATION | contributes_to | process | 0.88 |
| Retinal Ganglion Cell Degeneration | mediates | process | 0.85 |
| LPS-TLR4 pathway | activates | pathway | 0.85 |
| Blood-Brain Barrier Integrity | associated_with | phenotype | 0.85 |
| Alzheimer's Disease | risk_factor_for | disease | 0.85 |
| Blood-Brain Barrier Permeability | causes | phenotype | 0.85 |
| Parkinson'S Disease | causes | disease | 0.85 |
| glaucoma | promotes | disease | 0.80 |
| retinal ganglion cell degeneration | promotes | process | 0.80 |
| inflammaging | promotes | process | 0.80 |
| NLRP3 | activates | gene | 0.70 |
| SYNUCLEIN | associated_with | concept | 0.50 |
| Gut Microbiota | activates | process | 0.50 |
| α-SYNUCLEIN | associated_with | concept | 0.50 |
| CENTRAL NERVOUS SYSTEM | associated_with | concept | 0.50 |
| Gut Microbiome | activates | process | 0.50 |
| Telomere | activates | pathway | 0.50 |
| Reactive Oxygen Species | activates | process | 0.50 |
| Telomere | inhibits | pathway | 0.50 |
| Proteostasis | regulates | process | 0.50 |
| Cellular Senescence | regulates | cell_type | 0.50 |
| CHRONIC INFLAMMATION | regulates | concept | 0.50 |
| Telomere | regulates | pathway | 0.50 |
| Gut Microbiota | interacts_with | process | 0.50 |
| Gut Microbiota | causes | process | 0.50 |
| MAPK SIGNALING | activates | concept | 0.50 |
| Gut Microbiota | inhibits | process | 0.50 |
| Gut Microbiota | regulates | process | 0.50 |
| Gut Microbiota | associated_with | process | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Inflammation | associated_with | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Inflammation | activates | disease | 0.90 |
| INFLAMMATION | activates | gene | 0.90 |
| AGING | associated_with | gene | 0.90 |
| Als | activates | disease | 0.90 |
| Aging | associated_with | disease | 0.90 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 0.90 |
| INFLAMMATION | associated_with | gene | 0.90 |
| Parkinson | therapeutic_target | disease | 0.90 |
| PARKINSON | therapeutic_target | gene | 0.90 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.90 |
| Inflammation | treats | disease | 0.80 |
| OXIDATIVE STRESS | associated_with | gene | 0.80 |
| ALZHEIMER | regulates | gene | 0.80 |
| Alzheimer | regulates | disease | 0.80 |
| INFLAMMATION | treats | gene | 0.80 |
| IL-6 | therapeutic_target | gene | 0.80 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.80 |
| Inflammation | therapeutic_target | disease | 0.80 |
| INFLAMMATION | causes | gene | 0.80 |
| Inflammation | regulates | disease | 0.80 |
| Senescence | associated_with | disease | 0.80 |
| Inflammation | causes | disease | 0.80 |
| obesity | promotes | phenotype | 0.75 |
| FERROPTOSIS | associated_with | gene | 0.70 |
| Neuroinflammation | treats | disease | 0.70 |
| NEUROINFLAMMATION | treats | gene | 0.70 |
| NEUROINFLAMMATION | associated_with | gene | 0.70 |
| Neuroinflammation | associated_with | disease | 0.70 |
| Inflammation | interacts_with | disease | 0.70 |
| Neuroinflammation | interacts_with | disease | 0.70 |
| Als | regulates | disease | 0.70 |
| NEUROINFLAMMATION | interacts_with | gene | 0.70 |
| MITOCHONDRIA | associated_with | gene | 0.70 |
| depression | associated_with | phenotype | 0.70 |
| Depression | therapeutic_target | disease | 0.70 |
| DEPRESSION | therapeutic_target | gene | 0.70 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.70 |
| Depression | activates | disease | 0.70 |
| PARKINSON | associated_with | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| GUT-BRAIN AXIS | treats | gene | 0.70 |
| TNF | activates | gene | 0.70 |
| BDNF | activates | gene | 0.70 |
| IL-6 | activates | gene | 0.70 |
| TNF-Α | activates | gene | 0.70 |
| STROKE | activates | gene | 0.70 |
| DEPRESSION | activates | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Gut dysbiosis-driven monocyte reprogramming toward NETotic p | 0.380 | Alzheimer's disease | Systemic immune profiling and peripheral |
| plasma LPS-binding protein separates causal from compensator | 0.346 | neurodegeneration | How does gut microbiome dysbiosis contri |
| TLR4 priming is the actionable driver in: How does gut micro | 0.343 | neurodegeneration | How does gut microbiome dysbiosis contri |
| microglial inflammasome tone defines the therapeutic window | 0.341 | neurodegeneration | How does gut microbiome dysbiosis contri |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Iron and the Intestinal Microbiome. [PMID:40603801] | Li H | Adv Exp Med Biol | 2025 | 0 |
| Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP- [PMID:40958035] | Li Z, Sun X, Wang Y | Basic Res Cardiol | 2025 | 0 |
| Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and [PMID:38552431] | Wang W, Wang Y, Wang F, Xie G, Liu S, Li | Phytomedicine : international | 2024 | 0 |
| Joint-specific memory, resident memory T cells and the rolling window of opportu [PMID:38600215] | Chang MH, Fuhlbrigge RC, Nigrovic PA | Nat Rev Rheumatol | 2024 | 0 |
| Oral Microbiome: A Review of Its Impact on Oral and Systemic Health. [PMID:39338471] | Rajasekaran JJ, Krishnamurthy HK, Bosco | Microorganisms | 2024 | 0 |
| Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and [PMID:38552431] | Wang W, Wang Y, Wang F, Xie G, Liu S, Li | Phytomedicine : international | 2024 | 0 |
| Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting n [PMID:36601662] | ["Zhang Di", "Jing Bei", "Chen Zhen-Ni", | CNS neuroscience & therapeutic | 2023 | 0 |
| Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation [PMID:37435081] | Park, Hwang, Lee, Jang, Jeong et al. | Frontiers in immunology | 2023 | 0 |
| The role of the microbiota in glaucoma. [PMID:37866106] | Huang L, Hong Y, Fu X, Tan H, Chen Y, Wa | Molecular aspects of medicine | 2023 | 0 |
| Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation [PMID:37435081] | Unknown | Frontiers in immunology | 2023 | 0 |
| Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting n [PMID:36601662] | ["Zhang Di", "Jing Bei", "Chen Zhen-Ni", | CNS neuroscience & therapeutic | 2023 | 0 |
| The role of the microbiota in glaucoma. [PMID:37866106] | Huang L, Hong Y, Fu X, Tan H, Chen Y, Wa | Molecular aspects of medicine | 2023 | 0 |
| The role of Toll-like receptors and neuroinflammation in Parkinson's disease. [PMID:35668422] | ["Heidari Arash", "Yazdanpanah Niloufar" | Journal of neuroinflammation | 2022 | 0 |
| Pyroptosis in acute pancreatitis and its therapeutic regulation. [PMID:35687256] | Al Mamun A, Suchi SA, Aziz MA | Apoptosis | 2022 | 0 |
| Microglia in multiple sclerosis: Protectors turn destroyers. [PMID:35882229] | Yong | Neuron | 2022 | 0 |
| Microglia in multiple sclerosis: Protectors turn destroyers. [PMID:35882229] | Unknown | Neuron | 2022 | 0 |
| The role of Toll-like receptors and neuroinflammation in Parkinson's disease. [PMID:35668422] | ["Heidari Arash", "Yazdanpanah Niloufar" | Journal of neuroinflammation | 2022 | 0 |
| TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory sign [PMID:33057840] | ["Ciesielska A", "Matyjek M", "Kwiatkows | Cellular and molecular life sc | 2021 | 0 |
| Neuroinflammation in neurodegenerative disorders: the roles of microglia and ast [PMID:33239064] | Kwon, Koh | Translational neurodegeneratio | 2021 | 0 |
| AIM2 in regulatory T cells restrains autoimmune diseases. [PMID:33505023] | Chou WC, Guo Z, Guo H | Nature | 2021 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Dysbiosis in their description or question text
No additional research found